EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY-NC 4.0

Combined kidney and hematopoietic stem cell transplantation from the same donor: systematic review of clinical outcomes and limitations

Julia Modelska, Krzysztof Sadowski, Miłosz Miedziaszczyk, Axel Corona Deschamps, Ilona Idasiak-Piechocka

Journal of Medical Science · 31.03.2026 · 95 (1) · e1411

DOI: 10.20883/medical.e1411 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Journal of Medical Science, online erschienen am 31.03.2026. Verfasst von Julia Modelska und 4 weiteren Autor:innen. Die Arbeit nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Kidney transplantation is the most effective method of renal replacement therapy. The consequence of a conventional transplant is the need to use immunosuppressive drugs throughout life, which is associated with many side effects. A possible strategy for avoiding immunosuppressive therapy may be kidney transplantation from the same donor after hematopoietic cell transplantation (HSCT) or bone marrow transplantation (BMT). Material and methods. A systematic literature search was conducted in the PubMed, Scopus, Web of Science, and Cochrane databases using various combinations of keywords related to simultaneous or sequential kidney and bone marrow (or hematopoietic stem cell) transplantation from the same donor.

Results

Combined kidney and hematopoietic stem cell transplantation from the same donor has shown promising results, particularly in HLA-matched recipients, enabling withdrawal of immunosuppressive therapy without rejection. In HLA-mismatched cases, success was observed mainly with intensive conditioning regimens (e.g., total lymphoid irradiation, antithymocyte globulin, fludarabine). Early outcomes often included stable graft function and absence of acute rejection, but long-term follow-up revealed risks such as chronic rejection and declining renal function.

Conclusions

Despite encouraging outcomes, the approach remains experimental due to the lack of standardised protocols, validated biomarkers, and a complete understanding of chimerism persistence. Further clinical trials with long-term follow-up are needed to identify predictors of success, optimise conditioning strategies, and evaluate safety. The method holds potential, especially for patients with hematologic malignancies, but routine clinical application is not feasible.

Zitieren

APA

Modelska, J., Sadowski, K., Miedziaszczyk, M., Deschamps, A. C., & Idasiak-Piechocka, I. (2026). Combined kidney and hematopoietic stem cell transplantation from the same donor: systematic review of clinical outcomes and limitations. Journal of Medical Science, 95(1), e1411. https://doi.org/10.20883/medical.e1411

Vancouver

Modelska J, Sadowski K, Miedziaszczyk M, Deschamps AC, Idasiak-Piechocka I. Combined kidney and hematopoietic stem cell transplantation from the same donor: systematic review of clinical outcomes and limitations. Journal of Medical Science. 2026;95(1):e1411. doi:10.20883/medical.e1411

BibTeX
@article{Modelska2026,
  author = {Modelska, Julia and Sadowski, Krzysztof and Miedziaszczyk, Miłosz and Deschamps, Axel Corona and Idasiak-Piechocka, Ilona},
  title = {Combined kidney and hematopoietic stem cell transplantation from the same donor: systematic review of clinical outcomes and limitations},
  journal = {Journal of Medical Science},
  year = {2026},
  volume = {95},
  number = {1},
  pages = {e1411},
  doi = {10.20883/medical.e1411}
}
Kostenlos starten →